FDA To Investigate Role Of Context Of Risk Information In DTC Print Ads
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency will undertake two consumer studies to determine possible options for improving communication of risk information in ads.
You may also be interested in...
FDA Goes Online For DTC Brief Summary Research
The agency’s computer-based direct-to-consumer advertising study will allow FDA to learn how much time consumers spend reading the brief summary.
FDA Releases DTC Guidances; "Not The Last Word" On Ads, Commissioner McClellan Says
The agency pledges further review of its guidance on direct-to-consumer advertising. Broadcast ads for drugs and enforcement actions against repeat offenders could see more attention.
GAO Urges Congress To Place EPO, Other Dialysis Services In Bundled Rates
The Government Accountability Office recommends that Congress establish a bundled payment system for end-stage renal disease services - including Amgen's Epogen (epoetin) - under Medicare Part B "as soon as possible.